• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION ACTIVA; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION ACTIVA; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS) Back to Search Results
Model Number 37601
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Muscle Spasm(s) (1966); Therapeutic Response, Decreased (2271)
Event Date 01/01/2018
Event Type  Injury  
Manufacturer Narrative
Date of event.Please note that this date is based off of the publication year provided as the event dates were not provided in the published literature, nor was a full publication date available in the article.It was not possible to match this event with any previously reported event.Concomitant medical products: product id: 3389, lot# unknown, product type: lead.The main component of the system.Other relevant device(s) are: product id: 3389, serial/lot #: unknown, udi#: asku.Citation: brimley c, kershenovich a.Deep brain stimulation lead migration in a child secondary to osteogenesis at the burr hole site.Interdisciplinary neurosurgery.2018;12:27-29.Doi: 10.1016/j.Inat.2017.09.009.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Summary: the frequency of deep brain stimulation (dbs) complications is low; however, lead migration is a common way dbs therapy can become ineffective.We present a case of a (b)(6) male with generalized dystonia who underwent bilateral gpi dbs lead placement.The efficacy of the dbs system was diminished over two years and one of the leads was noted to be displaced on skull x-rays and confirmed with a head ct.During surgery to replace it, bone growth within the burr hole site was noted to have occurred and determined to be the cause for the lead migration.This is the first known case reporting osteogenesis at the burr hole site as a cause of lead migration.This complication should be kept in mind when performing dbs in children to refine a surgical technique that could prevent osteogenesis at the burr hole.Reported event: a (b)(6) male experienced increasing myoclonic activity, especially in the left side of the body, twenty-two months after implant surgery.It was thought that the dbs effectiveness had decreased.Ct scans and skull x-rays were obtained, and showed that the right dbs lead had migrated superiorly about 1 cm compared to prior (post-operative) images, out of the gpi location it had been in previously, with a new intracranial curvature close to the burr hole site.All the extracranial extensions and contacts looked unchanged compared to the prior skull x-ray images.Explorative surgery to revise the dbs lead was performed.Intraoperatively it was noticed that about 90% of the burr hole had been filled in and covered by newly formed bone, growing from deep to superficial, which explained the lead migration in the direction of the surface.The faster rate of bone growth in pediatric patients was concluded to have caused the upward migration of the lead.It was noted the inferior bony rim was removed as well as all of the exposed dura ma ter within the burr hole area at the time of initial lead placement.The authors noted they did not disregard the concept that the dura mater edges could have been involved in the new bone formation.The bone was removed with kerrison rongeurs, the old lead removed and a new lead was inserted stereotactically through a stereotactic head frame platform into the right gpi.Surgery was performed under general anesthesia.Upon follow-up, the patient's symptoms improved with an overall decrease in dystonic activity.Relevant patient medical history included secondary dystonia due to cerebral palsy, generalized severely disabling dystonic, opisthotonic like myoclonic jerks and history of prematurity, being born at (b)(6) gestation.The following device specifics were provided: lead model 3389, ins model 37601.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVA
Type of Device
IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7403010
MDR Text Key104571851
Report Number3007566237-2018-00994
Device Sequence Number1
Product Code MRU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H020007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 04/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number37601
Device Catalogue Number37601
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/07/2018
Initial Date FDA Received04/06/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age12 YR
-
-